1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App NL−F/NL−F knock-in mouse model of Alzheimer’s disease
(
- Contribution to journal › Article
- 2022
-
Mark
A clinical primer for the glymphatic system
(
- Contribution to journal › Scientific review
- 2019
-
Mark
On the Nature of β-Amyloid at Synapses
(
- Thesis › Doctoral thesis (compilation)
- 2012
-
Mark
Inhibition of Microglial Activation Protects Hippocampal Neurogenesis and Improves Cognitive Deficits in a Transgenic Mouse Model for Alzheimer's Disease
(
- Contribution to journal › Article
- 2010
-
Mark
Soluble TNF receptors are associated with Abeta metabolism and conversion to dementia in subjects with mild cognitive impairment.
(
- Contribution to journal › Article
-
Mark
No Association of VEGF Polymorphims with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Evaluation of plasma A beta(40) and A beta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
(
- Contribution to journal › Article
- 2009
-
Mark
Alzheimer's disease: No effect of the CDK5 gene on CSF biomarkers, neuropathology or disease risk
(
- Contribution to journal › Article
-
Mark
Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Concentrations of Metals, beta-Amyloid and Tau-Markers in Cerebrospinal Fluid in Patients with Alzheimer's Disease
(
- Contribution to journal › Article